Growing Neurological Diseases Along With Rising Diagnostics For Such Diseases Boosting The Global Vendor Neutral Archive (VNA) & PACS Market
According to a recently published report, the global Vendor Neutral Archive (VNA) & PACS Market has been expected to grow $5700milliontill 2022with aCAGR of 7.2% during 2016-2022. The segmentation of global vendor neutral archive (VNA) & PACS market is based on imaging instruments, delivery mode, vendors, procurement, components and regional outlook. The report on global vendor neutral archive (VNA) & PACS market forecast 2016-2022 (imaging instruments, delivery mode, vendors, procurement, components and Regional outlook and regional outlook) provides detailed overview and predictive analysis of the market.
Full report is available on global vendor neutral archive (VNA) & PACS market forecast 2016-2022 (imaging instruments, delivery mode, vendors, procurement, components and regional outlook)report at http://www.briskinsights.com/report/vendor-neutral-archive-vna-and-pacs-market
Neurological diseases and other related diseases are rising day by day owing to changing lifestyle, stress and so on. Other than this, there are more than 600 nervous diseases are there in the world such as epilepsy, brain tumors, alzheimer’s and stroke. Around 6.8 million peoples die worldwide every year with neurological diseases. Around 50 million peoples are suffering from epilepsy and approx. 24 million peoples are affected by alzheimer’s and other dementias. Such type of diseases requires ray, CT scan, MRI devices etc. to diagnose, which is ultimately driving the global vendor neutral archive (VNA) & PACS market upward. Rising chronic diseases like cancer, diabetes, cardiovascular disease augmenting the use of diagnostics tests in the medical field. Diagnostic tests areused to identify the type and adversity of diseases. This acts as an opportunity in the global vendor neutral archive (VNA) & PACS market.
Scope of the report
1. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKETBY TYPE OF IMAGING INSTRUMENTS 2012 - 2022 ($ million)
1.1. Magnetic Resonance Imaging
1.2. Ultrasound
1.3. Nuclear imaging
1.4. X ray
1.5. Computed tomography
1.6. others
2. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKETBY DELIVERY MODE 2012 - 2022 ($ million)
2.1. On-Site VNA
2.2. Fully Cloud-Hosted VNA
2.3. Hybrid VNA
3. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKETBY VENDORS 2012 - 2022 ($ million)
3.1. Independent Software Vendors
3.2. Infrastructure Vendors
4. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKETBY PROCUREMENT2012 - 2022 ($ million)
4.1. Multi-Departmental VNA
4.2. Multi-Site VNA
4.3. Departmental VNA
5. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET BY COMPONENTS2012 - 2022 ($ million)
5.1. Software and Services
5.1.1. Training services
5.1.2. Consulting
5.1.3. Implementation services
5.1.4. Support & maintenance
5.2. Hardware
5.2.1. Network devices
5.2.2. Access devices
5.2.3. Storage devices
5.2.4. Peripherals
5.2.5. Servers
6. GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKETREGIONAL OUTLOOK2012-2022($ million)
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Rest of the world
7. COMPANY PROFILES
7.1. ACUO Technologies (Perceptive Software)
7.2. AGFA Healthcare
7.3. Bridgehead Software
7.4. Carestream Health, Inc.
7.5. Dejarnette Research Systems, Inc.
7.6. Dell, Inc.
7.7. Fujifilm Corporation
7.8. GE Healthcare
7.9. Mach 7 Technologies
7.10. Mckesson Corporation
7.11. Merge Healthcare
7.12. Novarad Corporation
7.13. Philips Healthcare
7.14. Siemens Healthcare
7.15. Teramedica